• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by 3M Company

    5/30/25 8:15:17 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care
    Get the next $MMM alert in real time by email
    SD 1 a3mussecuritiesexchangecom.htm SD Document



    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, DC 20549

    FORM SD
    Specialized Disclosure Report
    3M COMPANY
    (Exact name of registrant as specified in Its charter)

    Delaware
    (State or other jurisdiction of incorporation)
    File No. 1-3285    41-0417775
    (Commission File Number)    (IRS Employer Identification No.)
    3M Center, St. Paul, Minnesota    55144-1000
    (Address of principal executive offices)    (Zip Code)

    Kelly Bysouth, Senior Vice President
    3M Strategic Sourcing & Packaging Solutions
    (651) 733-1110
    (Name and telephone number, including area code, of the person to contact in connection with this report.)

    Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

    x    Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2024.






    Section 1 — Conflict Minerals Disclosures

    Item 1.01 Conflict Minerals Disclosure and Report

    This Specialized Disclosure Report (“Form SD”) for 3M Company (“3M”) is provided in accordance with Rule 13p-1 under the Securities Exchange Act of 1934 (“Rule 13p-1”) for the reporting period from January 1 to December 31, 2024. References to 3M’s website are provided for convenience only, and its contents are not incorporated by reference into this Form SD or the attached Conflict Minerals Report, nor are they deemed filed with the U.S. Securities and Exchange Commission.

    In accordance with Rule 13p-1, 3M has filed this Form SD and the attached Conflict Minerals Report and both reports are posted to 3M’s Supplier Direct website (https://www.3m.com/3M/en_US/suppliers-direct/).

    Item 1.02 Exhibit
    The Conflict Minerals Report required by Item 1.01 of this Form SD is filed as Exhibit 1.01 hereto.

    Section 2 — Resource Extraction Issuer Disclosure

    Item 2.01 Resource Extraction Issuer Disclosure and Report
    Not applicable.

    Section 3 — Exhibits

    Item 3.01 Exhibits
    Exhibit 1.01 — Conflict Minerals Report for the period from January 1 to December 31, 2024, as required by Items 1.01 and 1.02 of this Form SD.




    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

    3M COMPANY    

    /s/ Torsten PilzMay 30, 2025
    By: Torsten Pilz(Date)
    Group President, Enterprise Supply Chain

    Get the next $MMM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MMM

    DatePrice TargetRatingAnalyst
    1/22/2025$140.00 → $170.00Equal Weight → Overweight
    Wells Fargo
    11/13/2024$184.00Neutral → Buy
    UBS
    10/22/2024Hold → Buy
    Melius
    9/6/2024$125.00Underweight
    Morgan Stanley
    7/30/2024$145.00Hold → Buy
    Argus
    7/29/2024$110.00 → $150.00Hold → Buy
    Deutsche Bank
    6/13/2024$125.00Peer Perform → Outperform
    Wolfe Research
    6/7/2024$105.00 → $120.00Neutral → Buy
    BofA Securities
    More analyst ratings

    $MMM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Group President Pilz Torsten

      4 - 3M CO (0000066740) (Issuer)

      6/3/25 2:57:05 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • Executive Vice President Banovetz John Patrick exercised 7,759 shares at a strike of $130.14 and sold $1,151,237 worth of shares (7,759 units at $148.37), decreasing direct ownership by 0.00% to 31,372 units (SEC Form 4)

      4 - 3M CO (0000066740) (Issuer)

      5/27/25 8:20:05 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • EVP, Chief Legal Off & Secret Rhodes Kevin H exercised 7,976 shares at a strike of $130.14 and sold $1,228,464 worth of shares (7,976 units at $154.02) (SEC Form 4)

      4 - 3M CO (0000066740) (Issuer)

      5/21/25 4:04:30 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • January 22, 2021 - Coronavirus (COVID-19) Update: January 22, 2021

      For Immediate Release: January 22, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA’s Office of Criminal Investigations recently investigated a case that has led to an arrest and the filing of a criminal complaint by the U.S. Department of Justice for introducing misbranded drugs into interstate commerce. The criminal investigation found th

      1/22/21 3:54:10 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care